Cargando…

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis

AIMS: To assess the effect of duration of hyperglycaemia before basal insulin (BI) initiation on clinical outcomes in type 2 diabetes (T2D). MATERIALS AND METHODS: Patients with T2D who initiated BI during 2009‐2013, had continuous enrolment for ≥2 years preceding and ≥1 year following BI initiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raccah, Denis, Guerci, Bruno, Ajmera, Mayank, Davis, Keith, Meyers, Juliana, Lew, Elisheva, Shaunik, Alka, Blonde, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613234/ https://www.ncbi.nlm.nih.gov/pubmed/31294079 http://dx.doi.org/10.1002/edm2.61

Ejemplares similares

Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin
por: Blonde, Lawrence, et al.
Publicado: (2018)

Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study
por: Jude, Edward B., et al.
Publicado: (2019)

Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)
por: Jude, Edward B., et al.
Publicado: (2019)

Hyperglycæmia Caused by Prolonged Administration of Insulin
por: Bose, J. P.
Publicado: (1949)

Hyperglycæmia Caused by Prolonged Administration of Insulin
Publicado: (1949)

A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database
por: Hagino, Hiroshi, et al.
Publicado: (2023)

Hyperosmolar non-ketotic hyperglycaemia during oral diazoxide therapy of prolonged hyperglycaemia in infancy.
por: Savage, J. M., et al.
Publicado: (1977)

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA
por: Blonde, Lawrence, et al.
Publicado: (2018)

Retrospective Analysis of the Burden of Illness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Versus Asthma in Commercially Insured US Patients
por: Bell, Christopher F, et al.
Publicado: (2023)

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes
por: Guerci, Bruno, et al.
Publicado: (2019)

Impact of delaying treatment intensification with a glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database
por: Tong, Liyue, et al.
Publicado: (2017)

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice
por: Blonde, Lawrence, et al.
Publicado: (2019)

Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L
por: Blonde, Lawrence, et al.
Publicado: (2020)

Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study
por: Pantalone, Kevin M., et al.
Publicado: (2023)

Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US
por: Shao, Hui, et al.
Publicado: (2022)

Hyperglycaemia and cancer risk
por: Asp, Nils-Georg
Publicado: (2007)

Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK
por: McCrimmon, Rory J., et al.
Publicado: (2022)

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study
por: Raccah, Denis, et al.
Publicado: (2009)

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
por: Lorenz, Martin, et al.
Publicado: (2017)

Multiple drugs: QTc prolongation, hyperglycaemia, off label use and drug exposure during pregnancy: case report
Publicado: (2021)

Causes of Hyperglycæmia during Operation
por: De, P., et al.
Publicado: (1946)

Norepinephrine: Hyperglycaemia: case report
Publicado: (2020)

Hyperglycaemia-Related Visual Seizure
por: Thu, Win Myat, et al.
Publicado: (2023)

Galangin, a dietary flavonoid, ameliorates hyperglycaemia and lipid abnormalities in rats with streptozotocin-induced hyperglycaemia
por: Aloud, Amal A., et al.
Publicado: (2018)

Hyperglycaemia in critically ill patients: the immune system’s sweet tooth
por: van Niekerk, Gustav, et al.
Publicado: (2017)

Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial
por: Giorgino, Francesco, et al.
Publicado: (2019)

Association of Genetic Variants with Isolated Fasting Hyperglycaemia and Isolated Postprandial Hyperglycaemia in a Han Chinese Population
por: Kong, Xiaomu, et al.
Publicado: (2013)

Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia
por: Rhou, Yoon Ji J, et al.
Publicado: (2022)

Hyperglycaemia, glycosuria and ketonuria may not be diabetes.
por: Gray, J., et al.
Publicado: (2003)

Steroid-induced hyperglycaemia in primary care
por: Mills, Edouard, et al.
Publicado: (2015)

The Cause of Hyperglycæmia under General Anæsthesia
por: De, P.
Publicado: (1946)

Glucagon orchestrates stress‐induced hyperglycaemia
por: Harp, J. B., et al.
Publicado: (2016)

Cigarette Smoking and Hyperglycaemia in Diabetic Patients
por: Sari, Mutiara Indah, et al.
Publicado: (2018)

Hyperglycaemia induced by isoniazid preventive therapy
por: Ganguly, Roshni Jhan, et al.
Publicado: (2018)

Hyperglycaemia on admission to hospital and COVID-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Hyperglycaemia-related occipital lobe seizures
por: Alakkas, A, et al.
Publicado: (2020)

Hyperglycaemia and Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2023)

Correction: Association of Genetic Variants with Isolated Fasting Hyperglycaemia and Isolated Postprandial Hyperglycaemia in a Han Chinese Population
por: Kong, Xiaomu, et al.
Publicado: (2013)

Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK
por: McCrimmon, Rory J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4di9d6743o9hgtm26an4i9s30